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The antidiabetic effects of Ge-Gen-Qin-Lian-Tang decoction (GQD) have been proven clinically. In a pharmacological study
conducted on STZ-induced diabetic rats, the constitutive aggregates/sediments of Ge-Gen-Qin-Lian-Tang decoction exhibited
stronger hypoglycemic and antioxidant activities compared to the soluble compositions. This study aims to demonstrate the
pharmacological properties of aggregates derived from GQD by measuring permeability of the active monomer phytochemicals
(e.g., baicalin) in a Caco-2 cell monolayer and determine the cellular viability, intracellular redox status (MDA and SOD), and
insulin secretion of pancreatic 𝛽-cell line, INS-1, following STZ-induced oxidative stress. The aggregates were separated into three
fractions, namely, “MA (microaggregates),” “400 g supernatant,” and “MNA (micro-/nanoaggregates),” by centrifugation at 400 ×g
and 15000×g, respectively. Aggregates in the sediment increased baicalin absorption, showed little toxicity to 𝛽-cells, elevated
intracellular SOD levels, and significantly suppressed oxidative damage effects on cellular viability and functions.The “MA” fraction
had a larger particle size and provided higher antioxidant cellular protection than “MNA” in vitro, implying that the sediments may
be the active components in the herbal decoction. The actions of these micro-/nanoaggregates may provide a new perspective for
understanding the antidiabetic effects of herbal decoctions and aid in interpretation of synergistic actions between the multiple
components.
1. Introduction
Herbal decoctions from traditional Chinesemedicine (TCM)
have always been an option for treating oxidative stress-
related chronic diseases [1–3], including diabetes. Many
active components have been identified from various medic-
inal plants, for example, flavonoids [4], polyphenols [5], and
organic acids and alkaloids, polypeptides, and polysaccha-
rides [1, 6]. These components may work alone as a single
chemical compound or, inmany instances, may deliver much
more potent therapeutic effects in synergy with other com-
ponents from the same plant or in a combination of different
herbs, as demonstrated in many herbal TCM studies [7–9].
Besides the assumption that multiple components may be
able to regulate several molecular pathways simultaneously,
the rich content of colloidal particles and aggregates formed
by various components in a decoction has been demonstrated
in TCM (Ma-Xing-Shi-Gan-Tang). In one such instance,
ephedrine and pseudoephedrine were mostly found to be
bound to colloidal nanoparticles which changed their bioac-
tivities [10] and this effect may provide the supramolecular
structures for these synergistic actions.
As a classic herbal TCM dating back to the East Han
Dynasty, Ge-Gen-Qin-Lian-Tang decoction (GQD) is pre-
pared from a formula composed of Radix Puerariae Lobatae,
Radix Scutellariae, Rhizoma Coptidis (Chinese goldthread),
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Radix Glycyrrhizae (licorice, honey-processed), and Zingiber
officinale Roscoe (ginger) and has been used for the clinical
treatments of type 2 diabetes and intestinal inflammation [11,
12]. GQD significantly reduced glycated hemoglobin (HbA1c)
and fasting blood glucose (FBG) in streptozotocin- (STZ-)
and high-fat-diet-induced diabetic SD rats and enhanced
glucose consumption in 3T3-L1 adipocytes [13]. In T2D
patients, GQD significantly reduced HbA1c, while regulating
the ecological structure of the gut microbiota by enriching
the amounts of beneficial bacteria, indicating that the gut is
among the important biological targets of this herbal tonic
[12].
GQDcontains severalwell-known active phytochemicals,
that is, baicalin [14, 15], berberine [16, 17], puerarin [18],
glycyrrhizic acid, and liquiritin [19], which are correlated to
the antidiabetic, antioxidant, and immunoregulative effects.
Apart from its antihyperglycemic and antioxidant activities,
baicalin is also known as a prolyl endopeptidase inhibitor
which induces apoptosis in pancreatic cancer cells [20, 21]
and it also induces apoptosis of lymphoma cells by down-
regulation of the PI3K/Akt signaling pathway [22]. However,
taking the plant-derived flavone baicalin as an example,
poor solubility and bioavailability are a common problem of
these phytochemicals when applied clinically, resulting in the
efficacy and pharmaceutical mechanisms of TCM decoctions
being often questioned.
In our previous studies, GQD was found to exert antihy-
perglycemic effects on streptozocin- (STZ-) induced diabetic
rats, while the micro-/nanoaggregates (sediments produced
after high speed centrifugation) showed stronger activities
than the supernatant on lowering blood glucose levels, ele-
vating fasting blood insulin and insulin secretion index and
increasing SOD activity of liver and pancreas [23].These data
implied that the micro-/nanoaggregates of TCM decoctions
may account for their therapeutic effects, being at least as
effective as the soluble components.The rich content of insol-
uble small molecules and self-assembled colloidal particles in
these decoctions may account for the formation of micro-/
nanometer scale aggregates by secondary aggregation. The
properties and functions of these aggregates warrant careful
and systematic study.
To understand the cellular functions and antihyper-
glycemic mechanisms of aggregates in GQD, their particu-
late characteristics and effects on cell proliferation, insulin
secretion, and redox status of pancreatic𝛽-cells were assessed
together with their impact on absorption of baicalin across
Caco-2 colonic epithelial cell monolayers in vitro.
2. Materials and Methods
2.1. Materials. The herbs used in this study, for example,
Radix Puerariae Lobatae, Radix Scutellariae, Rhizoma Cop-
tidis (Chinese goldthread), Radix Glycyrrhizae (licorice,
honey-processed), and sun-dried roots of Zingiber officinale
Roscoe (ginger) were purchased from Beijing Yanjing Chi-
neseMedicinal Herbs Co. Ltd. and authenticated by Professor
Chengzi Yang from Fujian University of Traditional Chinese
Medicine.
Cell culture medium (RPMI-1640, DMEM), HBSS buffer,
penicillin-streptomycin solution, and NEAA were from
HyClone (Xiamen, China); Fetal Bovine Serum (FBS)
was from Biological Industries (BIOIND); HEHPE, 0.25%
Trypsin-EDTA, L-glutathione (reduced), and MTT were
fromAMRESCOCo. Ltd. (USA); streptozocin (STZ), sodium
bicarbonate, and sodium pyruvate were from Sigma (USA).
Baicalin was purchased from the Fujian Institute for Food
and Drug Quality Control. Malondialdehyde (MDA), super-
oxide dismutase (SOD), and bicinchoninic acid (BCA) kits
were fromNanjing Jiancheng Biotechnology Institute; ELISA
kits for insulin measurements were purchased from Yanyu
Biotech (Shanghai) Co. Ltd.
2.2. Preparation of GQD,MA, andMNA. Ge-Gen-Qin-Lian-
Tang decoction (GQD) was prepared by soaking Radix Pue-
rariae Lobatae 72 g, Radix Scutellariae 27 g, Rhizoma Cop-
tidis 27 g, Radix Glycyrrhizae 18 g, and ginger 4.5 g in 1.2 L
deionized water for 30min at 25∘C and then boiled for
40min, cooled to room temperature, and filtered through two
layers of cotton gauze. The filtrate was named GQD. After
being centrifuged at 400×g for 5min, the sediment of GQD
was collected and resuspended with cell culture medium (the
same volume as GQD) and named “microaggregates (MA),”
while the supernatant was collected and named “400 g super-
natant.” Part of the supernatant was centrifuged at 15000×g
for 15min. The sediment was collected and resuspended to
obtain the sample named “micro-/nanoaggregates (MNA).”
2.3. Determination of Particle Size. The hydrodynamic diam-
eter of particles was determined by Dynamic Light Scattering
(DLS) analysis on a Zetasizer Nano device (Malvern Instru-
ments, Worcestershire, UK).
2.4. Cell Culture and MTT Assay. Human colonic epithelial
cells, Caco-2 (8 × 104 cells/mL, 200𝜇L/well), and rat pancre-
atic 𝛽-cell line, INS-1 (3 × 105 cells/mL, 200𝜇L/well), were
cultured at 37∘C under 5% CO2 and 95% relative humidity
for 24 h and used to evaluate the influence of GQD and
aggregates on cellular viability and proliferation using the
MTT assay. Samples were adjusted to the universal serial
concentrations in terms of dry weight of herbs (0.98, 1.95,
3.91, 7.81, 15.63, 31.25, 62.5, and 125mg/mL), added to the cells
in 96-well plates (200 𝜇L/well), and cultured for 12 h with
5 replicates for each concentration. The test was repeated 3
times.The cell survival rate was calculated with the following
equation (mean ± SD, 𝑛 = 5):
survival rate% = 𝐴570 nm sample
𝐴570nm control
× 100%. (1)
2.5. Permeability Tests on Caco-2 Cell Monolayers. Baicalin
concentrations were determined by an RPLC method as pre-
viously reported [24]. AnRPLC column,Daisogel-C18 (5 𝜇m,
4.6 × 250mm), was used with methanol-water-phosphoric
acid (47 : 53 : 0.2) as eluting buffer, flow rate of 1.0mL/min,
monitored at 280 nm; column temperature was set to 40∘C.
Permeability of GQD and its fractions was determined
following a previously described protocol [25]. Briefly, the
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Table 1: Average diameter of aggregates in centrifuged sediments of GQD.
Sample 𝑍-Average d (nm) Derived count rate (kcps)
Microaggregates (MA) 2775 ± 712 331 ± 17
Micro-/nanoaggregates (MNA) 531 ± 23 241 ± 2
𝑛 = 3; 𝑍-Average d (nm) is the average diameter of particles. Derived count rate (kcps) partially indicates the particle concentration. MA: the resuspended
sediment of GQD after low speed centrifugation (400×g);MNA: the resuspended sediment of GQDobtained by high speed centrifugation (15,000×g). Derived
count rate: the intensity of light scattered by particles, presented as “thousand counts per second (kcps).”
cells were seeded onto Transwell plates and allowed to form
a confluent monolayer over 20 days prior to the experiment.
On day 21, the test samples (0.4mL), namely, GQD, MA, and
MNA, were added to the apical side of the membrane and
0.6mL HBSS buffer was added to the basolateral side. The
transport of baicalin across the monolayer was monitored
over a 3-hour time period at 37∘C under 5% CO2. Samples
(100 𝜇L) were collected from the BL side at 30, 60, 90, 120, and
180min. HBSS buffer (100 𝜇L) was added to the BL side each
time the sample was collected. MA andMNA were dispersed
evenly in cell culture medium by vortexing.
The permeability coefficient (𝑃app) and absorption rate
(𝐴%) were calculated from the following equations (𝑛 = 3):
𝑃app =
(𝑑𝑄/𝑑𝑡)
𝐴 × 𝐶0
𝐴% = 100 × 𝑄
(𝐶0 × 𝑉)
,
(2)
where the unit of𝑃app is cm/s, 𝑑𝑄/𝑑𝑡 is the rate of permeation
of the drug across the cells (𝜇g/s), 𝐴 is the area of cell
monolayer, 𝐶0 is the donor compartment concentration at
time zero (𝜇g/mL), and 𝑄 is the total concentration of drug
transfer across the cell monolayer (𝜇g). 𝐶0 is obtained from
analysis of the dosing solution at the start of the experiment.
𝑉 is the volume of donor compartment.
2.6. Effects of GQD, MA, and MNA on STZ-Induced Cellular
Damage. INS-1 cells were seeded into 96-well plates, grown
for 24 h to form a confluentmonolayer, andwashedwith PBS.
GQD, MA, and MNA (each 100 𝜇L) were added with 100 𝜇L
STZ (IC50) and incubated for 12 h prior to MTT assay. Five
duplicates were used for each sample. The test was repeated 3
times. The cell survival rate was calculated with (1) and the
protection rate was calculated with the following equation
(means ± SD, 𝑛 = 5):
protection rate% =
(𝐴570sample − 𝐴570STZ)
(𝐴570Normal − 𝐴570STZ)
× 100%. (3)
2.7. Effects of GQD,MA, andMNA onMDA, SOD, and Insulin
Secretion. INS-1 cells (5.5 × 106 cells) were seeded into 12-
well plates and grown for 24 h to form a confluent monolayer.
GQD, MA, and MNA (each 500 𝜇L) were added with 500 𝜇L
STZ (IC50 = 46.4mM) and incubated for 12 h. Cells were
then washed with 1mL KRBB prior to the addition of 3.3mM
glucose (dissolved in KRBB) and incubated for 1 h. The
culture supernatants (500𝜇L) were collected and centrifuged
at 4∘C and 200×g for 10min and then stored at −20∘C. The
remaining KRBB was removed from cells before 16.7mM
glucose (dissolved in KRBB) was gently added and incubated
for 1 h.The supernatant collectionwas then repeated as above.
The cells were digestedwith pancreatin until 500𝜇L of culture
medium was added to stop the digestion.The cell suspension
was moved to 1.5mL tubes and centrifuged (4∘C, 200×g,
10min) to collect cells for MDA, SOD, insulin (INS), and
protein (bicinchoninic acid) assays.
2.8. Statistical Analysis. The raw data were processed with
EXCEL (Microsoft, Inc.) and SigmaPlot (Systat Software,
Inc.), and significance levels were determined by a one-way
ANOVA and indicated as 𝑃 < 0.05 or 𝑃 < 0.01.
3. Results and Discussion
3.1. Particle Size Distribution of GQD Aggregates. GQD was
separated into three fractions by centrifugation. As shown in
Figure 1, the aggregates in resuspended sediment produced
after low speed centrifugation (400×g) had an average
diameter of 2∼3 𝜇m. The remaining particles in the super-
natant were further separated with high speed centrifugation
(15,000×g) and resuspended to obtain a colloidal suspension
with particles having an average diameter around 530 nm
(Table 1) and a major size distribution from 300 nm to
1000 nm. This centrifugation primarily separated the aggre-
gates according to their average size and relative density,
although some small colloidal particles may still remain in
the supernatant of the 15,000×g centrifugation.
3.2. Increased Baicalin Absorption. As demonstrated by Lin
et al. [28], hydrophobic phytochemicals, that is, baicalin,
puerarin, and berberine hydrochloride, are dispersedwith the
assistance of components from the constituent herbs, result-
ing in elevated solubility. In combined use with berberine,
puerarin, glycyrrhizic acid, and liquiritin, the solubility and
absorption of baicalin were improved [29, 30]. As a purified
component, baicalin is barely soluble in aqueous solution and
has a very poor absorption rate of only 1% [26, 27].
In this study, the intestinal absorption of baicalin from
GQD was assessed in a Caco-2 cell monolayer model
for evaluating whether formation of aggregates altered the
bioavailability of Ge-Gen-Qin-Lian-Tang decoction (GQD).
The baicalin-containingGQD showed 5-fold higher𝑃app than
baicalin alone (Table 2). MA contained 48% of decocting
baicalin, exhibiting nearly twice 𝑃app and absorption rate
in comparison to GQD. Meanwhile, MNA representing
approx. 46% of total baicalin in the decoction exhibited
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Table 2: The apparent permeability (𝑃app) and absorption rate of baicalin across Caco-2 cell monolayers.
Sample Apical side baicalin concentration (𝜇g/mL) 𝑃app (×10−6 cm/s) Absorption rate in 3 h Absorption level
Pure baicalin∗ — 0.66 ± 0.10 ∼1% Low
GQD 27.6 3.40 ± 0.21 35% Medium
MA 12.9 6.60 ± 0.18 67% High
400 g supernatant 14.2 6.59 ± 0.29 66% High
MNA 12.8 7.30 ± 0.17 74% High
∗Data is cited from [26, 27]. 𝑛 = 4. 𝑃app > 5×10
−6 cm/s: high absorption; 𝑃app = 1∼5 × 10
−6 cm/s: medium absorption; 𝑃app < 1×10
−6 nm/s: low absorption.
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Figure 1: The particle size distribution of aggregates in GQD. (a)
Particle size distribution of MA; (b) particle size distribution of
MNA.Three duplicates were performed for each sample.
highest 𝑃app and absorption rate (Table 2). It is quite clear
that the inclusion of baicalin in the sediments, even in
terms of micrometer-scaled aggregates, strongly assisted
transportation of Ge-Gen-Qin-Lian-Tang decoction (GQD)
across the Caco-2 cell monolayers, significantly increasing its
absorption.
The absorption rate (𝐴%) of baicalin in GQD aggregates
across the Caco-2 cells monolayer (from apical side to
basolateral side) was determined at 30, 60, 90, 120, and
180min of incubation, as shown in Figure 2. Within the first
90min, the baicalin absorption rates of MA and MNA were
the same. After incubation for a longer time (2 h and 3 h),
the MNA exhibited an 8% higher absorption than the MA,
indicating that smaller particles may act as the more efficient
vehicle for baicalin. Meanwhile,𝐴% of baicalin in GQDwere
19% at 30min and 35% at 3 h, which were lower than those of
aggregates but higher than those of baicalin alone, implying
a significantly improved absorption in the herbal suspension
compared to the pure baicalin solution.
MA
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Figure 2: Absorption rate (𝐴%) of baicalin in GQD aggregates
on monolayers of Caco-2 cells. Baicalin concentrations in the
basolateral side solutions were determined by HPLC at different
time points (𝑛 = 4).
It is well known that the glycyrrhizic acid (a licorice-
derived glycoside) is capable of forming intermolecular
complexes to increase the solubility of poorly soluble drugs
[31]. Our earlier work has also shown that even aqueous
soluble plant-derived alkaloids (ephedrine) were mainly
carried by colloidal nanoparticles self-assembled in another
TCM herbal decoction and therefore exhibited different
pharmacological characteristics from own monomer of Ge-
Gen-Qin-Lian-Tang decoction (GQD) [10]. As demonstrated
above, higher 𝑃app and absorption rates of GQD aggregates
indicate that the inclusion of baicalin in the higher order
structures (i.e., supermolecular complexes and aggregates)
changes pharmacokinetics of Ge-Gen-Qin-Lian-Tang decoc-
tion (GQD) and may be essential for its synergistic actions in
the herbal decoction. Such complexes could be formed with
flavonoids (such as puerarin and liquiritin), alkaloids (such
as berberine), glycosides (such as baicalin and glycyrrhizic
acid), polysaccharides, and glycated proteins.
3.3. Influence of GQD and Its Aggregates on INS-1 Pancreatic
𝛽-Cell Proliferation. As shown in Figure 3, GQD suppressed
the growth of INS-1 pancreatic 𝛽-cells at 31.25∼62.50mg/mL,
implying a significant cytotoxicity (𝑃 < 0.01). However, at
lower concentrations (15.63mg/mL and lower), GQD showed
no inhibition on the cell proliferation but rather promotion of
such (max. 60% at 7.81mg/mL). In contrast, the aggregates,
both of MA and MNA, showed no cytotoxicity on INS-1
cells at concentrations as high as 125mg/mL. This indicates
BioMed Research International 5
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Figure 3: Effects of GQD and its aggregates on proliferation of
INS-1 pancreatic 𝛽-cells. 𝑛 = 5. GQD (in blue): compared with
normal controls, 0.98∼1.95mg/mL (𝑃 > 0.05), 15.63mg/mL (0.01 <
𝑃 < 0.05, “∗”), and others (𝑃 < 0.01, “∗∗”); MA (in orange):
400 g sediment, compared with normal controls, 125.0mg/mL and
1.95mg/mL (𝑃 > 0.05), 62.50 and 3.91mg/mL (0.01 < 𝑃 < 0.05,
“∗”), and others (𝑃 < 0.01, “∗∗”); MNA (in grey): 15000 g sediment,
compared with normal controls, 125.0mg/mL (𝑃 < 0.01, “∗∗”),
31.25mg/mL (0.01 < 𝑃 < 0.05, “∗”), and others (𝑃 > 0.05).
Error bars + SEM. Differences are significant according to a one-
way ANOVA indicated with an asterisk (𝑃 < 0.05; 𝑛 = 4) or double
asterisks (𝑃 < 0.01; 𝑛 = 4).
that most of the cytotoxic compositions of GQD are in the
supernatant after high speed centrifugation, which contains
the majority of aqueous solutes. At medium concentrations
(7.81∼62.5mg/mL), both MA and MNA mildly promoted
cell proliferation, while the larger sized aggregates (MA)
exhibited slightly higher proliferation rates, that is, 28% at
31.25mg/mL. The proliferation promoting activities of GQD
and its aggregates may be attributed to their intracellular
antioxidant capacities, since the pancreatic 𝛽-cells are sensi-
tive to oxidative stress.
The effective concentration of GQD and its fractions
appeared to be very high (in milligrams). It is because the
concentration was presented in terms of the total dry weights
of herbal materials used in preparing GQD. Given that the
decocting only extracts a small portion of herbal materials,
the dry weight of actual GQD dispersion and its aggregate
fractions would be many times lower.
3.4. Inhibition of STZ-Induced Cellular Oxidation. As shown
in Figure 4, GQD protected INS-1 cells from STZ-induced
oxidative damage by 23% at 7.81mg/mL but showed no
protection at higher or lower concentrations. In comparison,
bothMA andMNA significantly protected the cells at amuch
wider range of concentrations (1.95 to 31.25mg/mL) and
achievedmuch stronger protection (MA, 78% at 7.81mg/mL).
It indicates that antioxidants or components capable of
elevating the cellular antioxidant capacity are embedded in
the aggregates but not in the soluble fraction. Given that
neither MA nor MNA exhibited cytotoxicity (Figure 3), the
cytotoxic components of GQD are most likely to be in the
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Figure 4: Protection of GQD and its aggregates against STZ-
induced oxidative suppression of the growth of INS-1 𝛽-cells. 𝑛 = 5.
Oxidative damage was induced with STZ at its IC
50
(46.4mM).
GQD: compared with STZ controls, 31.25mg/mL (0.01 < 𝑃 <
0.05, labelled “∗”) and others (𝑃 > 0.05); MA: 400 g sediment,
compared with STZ controls, at all concentrations, 𝑃 < 0.01
(“∗∗”); MNA: 15000 g sediment, compared with STZ controls, at all
concentrations, 𝑃 < 0.01 (“∗∗”).
supernatant. Meanwhile, the larger sized aggregates generally
showed significantly higher protection rates (𝑃 < 0.01)
than the smaller sized aggregates. Notably, the protection
rates of MA were irrelevant to dosage, while those of MNA
were dose-dependent, indicating that these two groups of
aggregates may work via different mechanisms to inhibit
cellular oxidative damage.
The significantly elevated MDA level (Table 3) and
reduced SOD level (Table 4) indicated that INS-1 cells had
been damaged by STZ-induced oxidation. The aggregates
(both MA and MNA) significantly restored the cellular SOD
activity and reduced the MDA level, whereas GQD only
exhibited significant antioxidant effects at 7.81mg/mL. This
is consistent with the different performance of the aggregates
and GQD on regulating cellular viability (Figure 4). By com-
paring the MAD and SOD levels of GQD and its fractions,
their antioxidant activities were ranked in sequence: MA >
400 g supernatant >MNA > GQD.
The supernatant is rather high in antioxidant activity but
is toxic to the cells, implying that, at high GQD concen-
trations, the cytotoxic components overrule the antioxidant
(cytoprotective) components and therefore kill the cells.
3.5. Restoration of Insulin Secretion. The impacts of STZ-
induced oxidation and GQD samples on insulin secretion
from pancreatic 𝛽-cells were evaluated at either baseline
levels (3.3mM) or stimulated levels (16.7mM) of glucose,
as shown in Figure 5. The insulin secretion index (ISI) was
calculated as a ratio of glucose-stimulated insulin secretion
(GSIS)/basal insulin secretion (BIS) and data are shown in
Figure 6.
STZ-induced oxidation reduced the expression and secre-
tion of insulin, causing cells to be irresponsive to the glucose
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Table 3: GQD and components reduced STZ-induced MDA in pancreatic 𝛽-cell line, INS-1.
Group MDA (nmol/mL)
GQD MA 400 g supernatant MNA
7.81mg/mL herbs 9.40 ± 0.47ab 7.13 ± 1.71ab 8.29 ± 1.07ab 8.85 ± 0.77ab
3.91mg/mL herbs 9.81 ± 0.24ab 7.41 ± 1.55ab 8.78 ± 0.81ab 9.17 ± 0.60ab
1.95mg/mL herbs 10.06 ± 0.12a 7.49 ± 1.51ab 9.04 ± 0.67ab 9.37 ± 0.50ab
STZ control 10.25 ± 0.24a
Normal 5.89 ± 0.17b
𝑛 = 5; acompared with normal cells (𝑃 < 0.05); bcompared with STZ controls (𝑃 < 0.05).
Table 4: GQD and components restored SOD activity in STZ-treated pancreatic 𝛽-cell line, INS-1.
Group SOD (U/mg⋅protein)
GQD MA 400 g supernatant MNA
7.81mg/mL herbs 83.95 ± 5.32ab 133.33 ± 8.02b 106.44 ± 4.36ab 93.77 ± 8.87ab
3.91mg/mL herbs 66.22 ± 7.60a 127.40 ± 8.40ab 94.97 ± 5.35ab 85.63 ± 3.69ab
1.95mg/mL herbs 62.00 ± 6.56a 125.33 ± 5.51ab 87.93 ± 6.76ab 80.60 ± 4.23ab
STZ Control 60.75 ± 4.07a
Normal 155.88 ± 6.80b
𝑛 = 5; acompared with normal cells (𝑃 < 0.05); bcompared with STZ controls (𝑃 < 0.05).
stimulus. The baseline insulin secretion of normal INS-
1 𝛽-cells was 67 pg/mL, which was dramatically increased
threefold to the stimulated level of 214 pg/mL (ISI = 3.23).
In contrast, STZ-damaged cells did not respond to such a
stimulus. The presence of GQD did not improve the baseline
insulin secretion of STZ-damaged cells but doubled the
insulin secretion (max. 97 pg/mL,𝑃 < 0.01) at corresponding
elevated glucose levels.
Aggregates from GQD, namely MA and MNA, signif-
icantly improved both the baseline and stimulated insulin
secretions (𝑃 < 0.01, Figure 5). Notably, the larger size
aggregates (MA) showed much stronger restorative power
than the MNA, wherein the BIS was almost fully restored
and the GSIS (max. 174 pg/mL, ISI = 2.7) was about twofold
higher than that of MNA. The MNA significantly improved
the GSIS (max. ISI = 1.9) in a dose-dependent manner. Its
overall effects were rather like GQD, except that the effective
concentration of MNA was lower than that of GQD.
All the insulin secretion results were consistent with the
cellular protection and antioxidant effects of GQD and its
constitutive aggregates. The significant higher antioxidant
activity of aggregates on cells was in good agreement with
their antioxidant effects in vivo [23], wherein the aggregates
elevated SOD levels in pancreas, kidney, and liver of STZ-
induced diabetic rats. Despite the higher bioavailability of
baicalin in MNA demonstrated earlier in this study, the
aggregates in MA showed more potent protective effects
against STZ-induced oxidative stress upon cells. Although
it remains unclear why larger size aggregation particles
exhibited stronger antioxidant activity, one can anticipate
that such aggregates may have a higher content of free
radical scavenging compounds, such as berberine, puerarin,
liquiritin, and glycyrrhizin acid [15–19, 32]. Besides, the MA
is still a high absorption drug, whose absorption rate was only
7% lower than that ofMNA.The slightly lower absorption rate
could be compensated by the richer contents of particles in
MA indicated by their higher scattering light intensity (kcps).
Although the higher absorption rate and antioxidant and
cellular protective activities in vitro do not necessarily mean
better therapeutic effectiveness in vivo, it is reasonable to
anticipate that the micro-/nanoscale aggregates may have a
vital contribution to the overall antidiabetic effects of the
herbal decoction (GQD), noting that the herbal components
would eventually interact with themammalian digestive tract
in the form of multiple-order aggregates, such as chyle.
4. Conclusions
The antidiabetic herbal tonic, GQD, contains micro- and
nanoscale aggregates which improve the bioavailability of
insoluble phytochemicals, that is, baicalin, and possess little
cytotoxicity on colonic epithelial cells and pancreatic 𝛽-
cells (INS-1) in vitro. It also elevates cellular antioxidant
enzymes and protects 𝛽-cells from STZ-induced oxidation
and restores their insulin secretion capability.The centrifugal
separation results in two different size distribution fractions
of aggregates (centrifuge sediments), and the larger size
aggregates (MA) possessed stronger protection on cellular
viability and function of 𝛽-cells in vitro. These data are
consistent with an earlier antihyperglycemic study of GQD
aggregates on STZ-induced diabetic rats.The aggregates from
the TCM decoction, for the first time, have been found to
contain active components that contribute to the antidiabetic
activity of the herbal tonic by exhibiting antioxidant effects on
the endocrine cells and the carrying of insoluble compounds
across the intestinal mucosal barrier. These data also imply
that the aggregates and sediments in the herbal decoction
should be handled with greater care for both TCM herbal
medicine production and pharmacological studies.
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Figure 5: GQD and its aggregates restoration of insulin secretion in STZ-damaged INS-1 cells. “∗∗”: compared with normal cells, 𝑃 < 0.01,
𝑛 = 3; “##”: compared with STZ controls, 𝑃 < 0.01, 𝑛 = 3.
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Figure 6: GQD and its constitutive aggregates elevation of insulin
secretion index (ISI) of STZ-damaged INS-1𝛽-cells. “∗∗”: compared
with normal cells, 𝑃 < 0.01, 𝑛 = 3; “##”: compared with STZ
controls, 𝑃 < 0.01, 𝑛 = 3; ISI: GSIS/BIS.
In comparison with monomer compound studies, it
would require different approaches to elucidate the pharma-
cological mechanisms underpinning the therapeutic actions
of TCM aggregates and identify the constituent chemicals of
aggregates in different size. The particulates can be further
separated by ultrafiltration or size-exclusion chromatogra-
phy or ion-exchange chromatography according to their
physical size, for example, diameter, or surface charge. The
phase extraction and/or enzymatic hydrolysis can then be
applied to deconstruct these separated fractions of aggre-
gates, whose chemical compositions will be resolved with
chromatographic approach coupled with mass spectra. Thus,
more comprehensive studies on these colloidal micro-/
nanoparticles and their constituent compounds are war-
ranted to fully understand their pharmacological character-
istics and chemical natures, which may inspire and lead to
the development of active supramolecular complexes for the
treatment of oxidative diseases.
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